Physician profile
Keith E Earley
NPI 1174833602
$2,393.56
in general payments reported to CMS, 2019-2025
16 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.85 · 2021: $157 · 2022: $284 · 2023: $671 · 2024: $668 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915 · Education: $24.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.87 |
| Education | $24.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $594.92 | 2022-2025 | Argos, Clareon, Tryptyr |
| Abbvie INC. | $418.10 | 2022-2025 | Durysta |
| Amgen INC. | $326.58 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $187.37 | 2023-2024 | Vyzulta, Miebo, Lotemax Sm |
| Horizon Therapeutics Plc | $147.43 | 2023 | Tepezza |
| Sight Sciences, INC. | $136.95 | 2025 | Omni Surgical System |
| Ivantis, INC | $133.07 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $110.43 | 2024-2025 | Xdemvy |
| Rxsight INC | $107.49 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $65.38 | 2022 | |
| Sun Pharmaceutical Industries INC. | $44.48 | 2023 | Cequa |
| Ocular Therapeutix, INC. | $42.17 | 2022-2023 | Dextenza |
| Dompe US, INC. | $23.95 | 2022 | |
| Allergan, INC. | $23.65 | 2021 | |
| Thea Pharma INC. | $17.74 | 2024 | Iyuzeh |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Earley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.